307
Views
8
CrossRef citations to date
0
Altmetric
Research Articles

Factors associated with high-frequency illicit methadone use among rural Appalachian drug users

, PhD, MSSW, , DSW & , PhD
Pages 241-246 | Received 04 Jan 2013, Accepted 13 May 2013, Published online: 10 Jul 2013

References

  • Warner M, Chen LH, Makuc D. Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. National Center for Health Statistics Data Brief, No. 22. 2009: Hyattsville, MD
  • Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Detailed tables: National estimates, drug-related emergency department visits for 2004–2009. 2011. Available from: https://dawninfo.samhsa.gov/data/default.asp?met=All [last accessed 12 May 2011]
  • Piercefield E, Archer P, Kemp P, Mallonee S. Increase in unintentional medication overdose deaths Oklahoma, 1994–2006. Am J Prev Med 2010;39:357–363
  • Howard MO, Hall MT, Edwards J. Characteristics of young adult prescription opioid misusers in North Carolina: new findings and a proposed research agenda (technical report). 2009; Behavioral Health Resource Program, School of Social Work, University of North Carolina, Chapel Hill, NC
  • Bunn TL, Spiller HA, Singleton M. Surveillance of methadone-related poisonings in Kentucky using multiple data sources. Pharmacoepidemiol Drug Saf 2010;19:124–131
  • Substance Abuse and Mental Health Services Administration, Office of Applied Studies. 2010; National Survey of Drug Use and Health, Table 1.89B. Available from: http://oas.samhsa.gov/NSDUH/2k9NSDUH/tabs/Sect1peTabs47to92.htm#Tab1.89B [last accessed 17 Nov 2010]
  • Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the future national survey results on drug use, 1975–2009: Volume I, Secondary school students. NIH Publication No. 10-7584. Bethesda (MD): National Institute on Drug Abuse; 2010
  • Ompad DC, Fuller CM, Chan CA, Frye V, Vlahov D, Galea S. Correlates of illicit methadone use in New York City: a cross-sectional study. BMC Public Health 2008;8:375
  • Brugal MT, Barrio G, De F, Regidor E, Rpyuela L, Suelves JM. Factors associated with non-fatal heroin overdose: assessing the effect of frequency and route of heroin administration. Addiction 2002;97:319–327
  • Degenhardt L, Bucello C, Mathers B, Briegleb C, Ali H, Hickman M, McLaren J. Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 2011;106:32–51
  • Kerr T, Fairbaim N, Tyndall M, Marsh D, Li K, Montaner J, Wood E. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend 2007;87:39–45
  • Ochoa KC, Davidson PJ, Evans JL, Hahn JA, Page-Shafer K, Moss AR. Heroin overdose among young injection drug users in San Francisco. Drug Alcohol Depend 2005;80:297–302
  • Havens JR, Oser CB, Knudsen HK, Lofwall M, Stoops WW, Walsh SL, Leukefeld CG, Kral AH. Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. Drug Alcohol Depend 2011;115:107–112
  • Heckathorn DD. Respondent-driven sampling: a new approach to the study of hidden populations. Social Problems 1997;44:174–199
  • Abdul-Quader AS, Heckathorn DD, McKnight C, Bramson H, Nemeth C, Sabin K, Gallagher K, Des Jarlais DC. Effectiveness of respondent-driven sampling for recruiting drug users in New York City: findings from a pilot study. J Urban Health 2006;83:459–476
  • Wang J, Falck RS, Li L, Rahman A, Carlson RG. Respondent-driven sampling in the recruitment of illicit stimulant drug users in a rural setting: findings and technical issues. Addict Behav 2007;32:924–937
  • McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M. The fifth edition of the addiction severity index. J Subst Abuse Treat 1992;9:199–213
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59:22–33
  • Freeman LC. Centrality in social networks: conceptual clarification. Social Networks 1979;1:215–239
  • Rothenberg RB, Potterat JJ, Woodhouse DE, Muth SQ, Darrow WW, Klovdahl AS. Social network dynamics and HIV transmission. AIDS 1998;12:1529–1536
  • Bell DC, Atkinson JS, Carlson JW. Centrality measures for disease transmission networks. Soc Netw 1999;21:1–21
  • Rothenberg RB, Potterat JJ, Woodhouse DE, Darrow WW. Choosing a centrality measure: Epidemiologic correlates in the Colorado Springs study of social networks. Soc Netw 1995;17:273–297
  • Rothenberg R, Sterk C, Toomey K, Potterat JJ, Johnson D, Schrader M, Hatch S. Using social network and ethnographic tools to evaluate syphilis transmission. Sex Transm Dis 1998;25:154–160
  • De P, Singh AE, Wong T, Yacoub W, Jolly A. Sexual network analysis of a gonorrhea outbreak. Sex Transm Infect 2004;80:280–285
  • Bonacich P. Factoring and weighting approaches to status scores and clique identification. J Math Sociol 1972;2:113–120
  • Havens JR, Lofwall MR, Frost SDW, Oser CB, Leukefeld CG. Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users. Am J Public Health 2013;103:e44–e52
  • Seidman S. Network structure and minimum degree. Social Networks 1983;5:269–287
  • Friedman SR, Neaigus A, Jose B, Curtis R, Goldstein M, Ildefonso G, Rothenberg RB, Des Jarlais DC. Sociometric risk networks and risk for HIV infection. Am J Public Health 1997;87:1289–1296
  • Paulozzi LJ, Logan JE, Hall AJ, McKinstry E, Kaplan JA, Crosby AE. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009;104:1541–1548
  • United States Government Accountability Office. Methadone-associated overdose deaths: Factors contributing to increased deaths and efforts to prevent them, GAO-09-341. 2009; Available from: http://www.gao.gov/new.items/d09341.pdf [last accessed 15 Nov 2010]
  • Gottheil E, McLellan AT, Druley KA. Length of stay, patient severity and treatment outcome: sample data from the field of alcoholism. J Stud Alcohol Drugs 1992;53:69–75
  • Hubbard RL, Craddock SG, Anderson J. Overview of 5-year followup outcomes in the drug abuse treatment outcome studies (DATOS). J Subst Abuse Treat 2003;25:125–134
  • Zarkin GA, Dunlap LJ, Bray JW, Wechsberg WM. The effect of treatment completion and length of stay on employment and crime in outpatient drug-free treatment. J Subst Abuse Treat 2002;23:261–271
  • Warner BD, Leukefeld CG. Rural-urban differences in substance use and treatment utilization among prisoners. Am J Drug Alcohol Abuse 2001;27:268–280
  • Office of Applied Studies, Substance Abuse and Mental Health Services Administration. The DASIS Report: distance to substance abuse treatment facilities among those with alcohol dependence or abuse. 2002. Available from: http://www.samhsa.gov/data/2k2/distance/distance.htm
  • Lenardson J, Gale JA. Distribution of substance abuse treatment facilities across the rural-urban continuum. Muskie School of Public Service, Maine Rural Health Research Center, University of Southern Maine. Available from: Available from: http://muskie.usm.maine.edu/Publications/rural/pb35bSubstAbuseTreatmentFacilities.pdf
  • McCabe SE, Boyd CJ, Teter CJ. Subtypes of nonmedical prescription drug misuse. Drug Alcohol Depend 2009;102:63–70
  • Rigg KK, Ibanez GE. Motivations for non-medical prescription drug use: a mixed methods analysis. J Subst Abuse Treat 2010;39:236–247
  • Hall MT, Howard MO, McCabe SE. Subtypes of adolescent sedative/anxiolytic misusers: a latent profile analysis. Addict Behav 2010;35:882–889
  • Toblin RL, Paulozzi LJ, Logan JE, Kaplan JA. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. J Clin Psychiatry 2010;71:491–496
  • Cicero TJ, Lynskey M, Todorov A, Inciardi JA, Surratt HL. Co-morbid pain and psychopathology in males and females admitted to treatment for opioid analgesic abuse. Pain 2008;139:127–135
  • Berg KM, Arnsten JH, Sacaijiu G, Karasz A. Providers’ experiences treating chronic pain among opioid-dependent drug users. J Gen Intern Med 2009;24:482–488
  • Wachholtz A, Ziedonis D, Gonzalez G. Comorbid pain and opioid addiction: psychosocial and pharmacological treatments. Subst Use Misuse 2011;46:1536–1552
  • Jonas AB, Young AM, Oser CB, Leukefeld CG, Havens JR. OxyContin® as currency: OxyContin® use and increased social capital among rural Appalachian drug users. Soc Sci Med 2012;74:1602–1609
  • Davidson PJ, McLean RL, Kral AH, Gleghorn AA, Edlin BR, Moss AR. Fatal heroin-related overdose in San Francisco, 1997–2000: a case for targeted intervention. J Urban Health 2003;80:261–273
  • Latkin CA, Hua W, Tobin K. Social network correlates of self-reported non-fatal overdose. Drug Alcohol Depend 2004;73:61–67

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.